ClinicalTrials.Veeva

Menu

A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

Pfizer logo

Pfizer

Status and phase

Terminated
Phase 2

Conditions

Small Cell Lung Carcinoma

Treatments

Drug: Cisplatin (Or Carboplatin)
Drug: Etoposide
Drug: figitumumab

Study type

Interventional

Funder types

Industry

Identifiers

NCT00977561
A4021032

Details and patient eligibility

About

This study will summarize the safety of patients receiving figitumumab combined with etoposide and cisplatin (or carboplatin) vs. patients receiving etoposide and cisplatin (or carboplatin) alone as first line treatment for extensive stage disease Small Cell Lung Cancer.

Full description

The study prematurely discontinued on January 26, 2011 due to slow enrollment. It should be noted that safety concerns have not been seen in this study and have not factored into this decision.

Enrollment

9 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically confirmed diagnosis of extensive stage disease Small Cell Lung Cancer (SCLC), with tumor biopsy sample required.
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. Total IGF-1 > or = 120 ng/ml

Exclusion criteria

  • Any prior systemic therapy for Small Cell Lung Cancer (SCLC)
  • HbA1c > or = 5.7%

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

9 participants in 2 patient groups

Arm A
Experimental group
Description:
Figitumumab (CP-751,871) Plus Chemotherapy \[Cisplatin (Or Carboplatin) And Etoposide\] All drugs to be administered on a 21 day cycle
Treatment:
Drug: Etoposide
Drug: Cisplatin (Or Carboplatin)
Drug: Etoposide
Drug: Cisplatin (Or Carboplatin)
Drug: figitumumab
Arm B
Active Comparator group
Description:
Chemotherapy \[Cisplatin (Or Carboplatin) And Etoposide\] All drugs to be administered on a 21 day cycle
Treatment:
Drug: Etoposide
Drug: Cisplatin (Or Carboplatin)
Drug: Etoposide
Drug: Cisplatin (Or Carboplatin)

Trial contacts and locations

51

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems